Radium-223 for Patients with Metastatic Castration-Resistant Prostate Cancer with Asymptomatic Bone Metastases Progressing on First-Line Abiraterone Acetate or Enzalutamide: A Single-Arm Phase II Trial.
European Journal of Cancer(2022)
关键词
Radium-223,AR-V7,Bone metastases,Metastatic castration-resistant prostate cancer
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要